Pacific Biosciences of California (PACB) Short Interest Ratio & Short Volume

Short interest is the volume of Pacific Biosciences of California shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 48,520,000 shares of PACB short. Learn More on Pacific Biosciences of California's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PACB shares currently have a short interest ratio of 5.0. Learn More on Pacific Biosciences of California's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pacific Biosciences of California: IMC Chicago LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Pacific Biosciences of California saw a decline in short interest in April. As of April 15th, there was short interest totaling 48,520,000 shares, a decline of 1.1% from the previous total of 49,050,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Pacific Biosciences of California: Nautilus Biotechnology, Inc. (1.95%), Akoya Biosciences, Inc. (4.74%), Quanterix Co. (3.21%), Harvard Bioscience, Inc. (1.55%), Seer, Inc. (5.96%), Standard BioTools Inc. (3.05%), Bionano Genomics, Inc. (8.85%), Cytek Biosciences, Inc. (6.29%), Accelerate Diagnostics, Inc. (2.90%), EyePoint Pharmaceuticals, Inc. (13.12%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

Short selling PACB is an investing strategy that aims to generate trading profit from Pacific Biosciences of California as its price is falling. PACB shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Pacific Biosciences of California occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PACB, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PACB, twice per month. The most recent reporting period available is April, 15 2024.